Advanced therapies and treatment approaches in mental health care are fostering a more balanced life for individuals. Integrating these methods and providing services in a spa-like environment enhances patient outcomes and speeds up recovery.
NorCal Neurostimulation stands out in this field by offering transformative treatments that surpass traditional psychiatric practices.
NorCal Neurostimulation specializes in Neurostar advanced transcranial magnetic stimulation (TMS) therapy, which is a non-medication, non-invasive, FDA-approved treatment for depression in those aged 15 and older, as well as anxious depression and obsessive-compulsive disorder. NorCal Neurostimulation also offers the latest accelerated TMS protocols. This condenses a typical six to nine-week treatment course into as little as five days, providing quicker relief for patients. NorCal’s approach is focused on providing personalized care and innovative therapies, setting new standards in mental health treatments that improve the quality of life.
“Our array of tools allows us to provide an exceptional level of patient care, ensuring adequate support to meet patients’ specific needs,” says Dr. Lauren Marasa, Co-founder and CEO at NorCal Neurostimulation.
It takes patient care to a whole new level by going the extra mile to provide cutting-edge treatment and personalized care. The company focuses on interventional psychiatry and neuromodulation. Its rigorous approach facilitates a thorough evaluation and personalized treatment plan for every patient. For those with treatment-resistant mental illness, the doctors may order genetic testing to help guide the treatment plan or order specific lab tests that may lead to further diagnostic clarification.
Focused on offering all FDA-approved treatment options for treatment-resistant depression, NorCal is developing an esketamine (Spravato) program for those with severe depression or suicidal tendencies. The company also partners with a local hospital in Sacramento to offer electroconvulsive therapy (ECT) and IV ketamine for select patients. This ensures their patients receive the most appropriate and effective care.
One of their patients discusses his response with ECT, stating, “My depression had become so extreme that it took with it any want for me to live. And now, after ECT, both depression and any death wish have been shown the door. This lifesaving transformation was orchestrated by the skilled and loving hands of Dr. Marasa and Dr. Voronina. They not only gave me my life back, but also created a brand-new life and existence I never thought possible.”
Another TMS patient credits the team at NorCal Neurostimulation for saving her life, noting that prior to seeking treatment there, her major depressive disorder was ‘tormenting’ her. She is happy to report that after TMS treatment, she has a newfound hope, freedom and capacity to take on life again.
Dr. Marasa says she loves the work they do because of the personal relationships she and her team builds with their patients and says that these dramatic, life-changing and transformative stories are not unique to those above but quite common amongst their patients making their day to day work extremely rewarding.
NorCal’s expertise in interventional psychiatry and neuromodulation has been recognized as the best abstract submission by the International Society for ECT and Neurostimulation (ISEN) in 2023. This recognition is attributed to its innovative approach of combining ECT with IV ketamine, underscoring the commitment to advancing psychiatric care and providing the most effective treatments for each of its patients.
Our array of tools allows us to provide an exceptional level of patient care, ensuring adequate support to meet patients’ specific needs
Dedication to personalized care is evident in Norcal’s thorough patient consultations. During these sessions, their team takes the time to understand each patient’s psychiatric history and discuss the potential risks and benefits of various treatment options. This approach allows the doctors to customize the treatment plans, combining different therapies to achieve the best outcomes.
One of the most significant challenges in mental health care is the stigma surrounding treatment and the limited access to comprehensive care. NorCal works tirelessly to break down these barriers by fostering compassionate and supportive care. It creates a space where patients feel safe and respected while ensuring the assistance they need is available without having to endure long wait times. Accessibility is another major hurdle, and NorCal is committed to addressing it. The company’s services are covered under most insurance plans, including Medicare, making them affordable and accessible to a broader range of patients. Its client-centric approach ensures that financial barriers do not prevent patients from receiving the care they need.
Dr. Marasa says, looking ahead, the company plans to incorporate further wellness and self-care treatment modalities as they aim to create a space where patients want to keep coming to feel their best.
NorCal’s commitment to offering comprehensive services in a welcoming and supportive environment has set the benchmark in psychiatric care. Its innovative treatments and commitment to breaking the stigma surrounding mental health solidify its position as a trusted partner for those seeking transformative care.
